Fifth Third Bancorp’s Genomic Health, Inc. GHDX Stock Holding History

Fifth Third Bancorp’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-50	Closed	-$2K	–	2303
2017 Q1	$2K	Sell	50 -8	-14%	-$237	﹤0.01%	2021
2016 Q4	$2K	Buy	+58	New	+$1.77K	﹤0.01%	2096
2015 Q4	–	Sell	-108	Closed	-$2K	–	2962
2015 Q3	$2K	Sell	108 -92	-46%	-$2.37K	﹤0.01%	2674
2015 Q2	$6K	Hold	200	–	–	﹤0.01%	2268
2015 Q1	$6K	Hold	200	–	–	﹤0.01%	2186
2014 Q4	$6K	Hold	200	–	–	﹤0.01%	2092
2014 Q3	$6K	Hold	200	–	–	﹤0.01%	2146
2014 Q2	$5K	Hold	200	–	–	﹤0.01%	2173
2014 Q1	$5K	Sell	200 -350	-64%	-$10K	﹤0.01%	2151
2013 Q4	$16K	Hold	550	–	–	﹤0.01%	1737
2013 Q3	$17K	Buy	550 +350	+175%	+$11.7K	﹤0.01%	1726
2013 Q2	$6K	Buy	+200	New	+$6.57K	﹤0.01%	1913

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Fifth Third Bancorp's GHDX Position: Q2 2017 in Review

Fifth Third Bancorp sold out of Genomic Health, Inc. (GHDX) in Q2 2017, closing a stake of 50 shares — an estimated $2K sold.

Fifth Third Bancorp first reported a position in GHDX in Q2 2013 and held it in 12 quarters. The position peaked at $17K in Q3 2013. 124 funds tracked by Wall St. Rank hold GHDX as of Q2 2017.

Fifth Third Bancorp reported no remaining Genomic Health, Inc. position as of Q2 2017 after selling out during the quarter.
Fifth Third Bancorp sold 50 Genomic Health, Inc. shares in Q2 2017, an estimated $2K.
Fifth Third Bancorp first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 12 quarters.
Fifth Third Bancorp's Genomic Health, Inc. position peaked at $17K in Q3 2013.
124 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2017.

Based on Fifth Third Bancorp's 13F filing for Q2 2017, filed 11 Aug 2017.